CCDC93 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.780300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.788300E-02
Normal-vs-Stage2
8.536600E-03
Normal-vs-Stage3
7.141900E-02
Normal-vs-Stage4
1.406830E-01
Stage1-vs-Stage2
7.068200E-01
Stage1-vs-Stage3
1.673560E-02
Stage1-vs-Stage4
8.041800E-01
Stage2-vs-Stage3
5.450000E-02
Stage2-vs-Stage4
9.847800E-01
Stage3-vs-Stage4
1.414990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.996400E-03
Normal-vs-AfricanAmerican
6.331700E-02
Normal-vs-Asian
6.942100E-03
Caucasian-vs-AfricanAmerican
9.541600E-01
Caucasian-vs-Asian
1.197390E-01
AfricanAmerican-vs-Asian
2.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.394030E-02
Normal-vs-Female
3.999500E-03
Male-vs-Female
5.495000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.440810E-01
Normal-vs-Age(41-60Yrs)
7.977200E-03
Normal-vs-Age(61-80Yrs)
8.357400E-03
Normal-vs-Age(81-100Yrs)
1.207850E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.287600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.379800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.952600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.338200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.800200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.675800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.375910E-03
Normal-vs-Daily Drinker
8.991800E-04
Normal-vs-Weekly Drinker
3.284000E-02
Normal-vs-Occasional Drinker
2.207900E-02
Normal-vs-Social Drinker
4.576100E-02
Non Drinker-vs-Daily Drinker
5.333200E-01
Non Drinker-vs-Weekly Drinker
2.226000E-01
Non Drinker-vs-Occasional Drinker
7.090400E-02
Non Drinker-vs-Social Drinker
1.292090E-02
Daily Drinker-vs-Weekly Drinker
1.029010E-01
Daily Drinker-vs-Occasional Drinker
2.524000E-02
Daily Drinker-vs-Social Drinker
4.196200E-03
Weekly Drinker-vs-Occasional Drinker
7.299800E-01
Weekly Drinker-vs-Social Drinker
3.306000E-01
Occasional Drinker-vs-Social Drinker
4.655600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.369800E-01
Normal-vs-Grade 2
6.772600E-01
Normal-vs-Grade 3
6.609200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.597000E-01
Grade 1-vs-Grade 3
5.013800E-01
Grade 1-vs-Grade 4
3.369800E-01
Grade 2-vs-Grade 3
7.272400E-01
Grade 2-vs-Grade 4
6.772600E-01
Grade 3-vs-Grade 4
6.609200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.776200E-03
Normal-vs-NonDiabetic
3.264500E-03
Diabetic-vs-NonDiabetic
3.814800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.582200E-02
Normal-vs-NoPancreatitis
1.718230E-03
Pancreatitis-vs-NoPancreatitis
5.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.516200E-03
Normal-vs-N1
9.436900E-03
N0-vs-N1
6.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.848100E-02
Normal-vs-TP53-NonMutant
2.785800E-02
TP53-Mutant-vs-TP53-NonMutant
9.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
